ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Illinois » Internal Medicine

Top Internal Medicine Prescribers in Illinois

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CHAD JOHNSTON MD

Internal Medicine

0

$0

0
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

0%
prescriptions for brand name drugs

Avg: 25%

$0
Average prescription price

Avg: $60

BELLA ROSENZWEIG MD SC

Internal Medicine

0

$0

0
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

0%
prescriptions for brand name drugs

Avg: 25%

$0
Average prescription price

Avg: $60

ANDREA ITZKOWITZ M.D.

Internal Medicine

3,468

$104

159
135 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 25%

$0
Average prescription price

Avg: $60

MENSUR SUNJE M.D. M.SC.

Internal Medicine

414

$4,513

134
50 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

62%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

4%
prescriptions for brand name drugs

Avg: 25%

$11
Average prescription price

Avg: $60

MATTHEW WILKINSON M.D.

Internal Medicine

315

$3,729

183
115 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

6%
prescriptions for brand name drugs

Avg: 25%

$12
Average prescription price

Avg: $60

WORLALI NUTAKOR M.D.

Internal Medicine

344

$4,507

226
124 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

26%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

6%
prescriptions for brand name drugs

Avg: 25%

$13
Average prescription price

Avg: $60

SAM GAINES M.D.

Internal Medicine

346

$4,666

213
90 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

44%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 25%

$13
Average prescription price

Avg: $60

TARA RAMSEY M.D.

Internal Medicine

304

$4,297

178
102 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

29%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

8%
prescriptions for brand name drugs

Avg: 25%

$14
Average prescription price

Avg: $60

BRIAN HUGHES M.D.

Internal Medicine

384

$6,012

229
142 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

30%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 25%

$16
Average prescription price

Avg: $60

HILTON GORDON MD

Internal Medicine

510

$8,009

159
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

88%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

4%
prescriptions for brand name drugs

Avg: 25%

$16
Average prescription price

Avg: $60

CHRISTOPHER POTTMEYER M.D.

Internal Medicine

199

$3,379

126
51 are 65+

10%
patients receiving schedule two controlled substances

Avg: 1%

45%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 25%

$17
Average prescription price

Avg: $60

PRITH GOOMAR M.D.

Internal Medicine

300

$5,147

76
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

43%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

5%
prescriptions for brand name drugs

Avg: 25%

$17
Average prescription price

Avg: $60

SUJAL DESAI D.O

Internal Medicine

136

$2,388

51
40 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

37%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$18
Average prescription price

Avg: $60

ILAXI PATEL D.O.

Internal Medicine

419

$7,841

283
215 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$19
Average prescription price

Avg: $60

AHMED TARIQ DO

Internal Medicine

830

$16K

92
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

6%
prescriptions for brand name drugs

Avg: 25%

$19
Average prescription price

Avg: $60

CAROLYN TRELKA-ROJAS M.D.

Internal Medicine

395

$7,905

27
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

8%
prescriptions for brand name drugs

Avg: 25%

$20
Average prescription price

Avg: $60

ADAM BERRY M.D.

Internal Medicine

641

$13.1K

100
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 25%

$20
Average prescription price

Avg: $60

PRASUN DAS MD

Internal Medicine

435

$8,910

321
276 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 25%

$20
Average prescription price

Avg: $60

TRUSHIL SHAH M.D.

Internal Medicine

412

$9,533

34
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 25%

$23
Average prescription price

Avg: $60

SUSAN WOO MD

Internal Medicine

635

$15.5K

98
94 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

6%
prescriptions for brand name drugs

Avg: 25%

$24
Average prescription price

Avg: $60

JELVEH JAHANGIRI MD

Internal Medicine

1,001

$25.9K

45
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

6%
prescriptions for brand name drugs

Avg: 25%

$26
Average prescription price

Avg: $60

GURBACHAN CHADHA MD

Internal Medicine

811

$21.6K

36
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$27
Average prescription price

Avg: $60

ARSENIO AGNGARAYNGAY M.D.

Internal Medicine

1,025

$29.2K

58
48 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 25%

$28
Average prescription price

Avg: $60

MARIA RIVERA MD

Internal Medicine

912

$26.5K

60
56 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 25%

$29
Average prescription price

Avg: $60

MANJIT MARWAH MD

Internal Medicine

632

$18.4K

44
35 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 25%

$29
Average prescription price

Avg: $60

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank